Independence Bank of Kentucky raised its holdings in Humana Inc. (NYSE:HUM – Free Report) by 14,650.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 295 shares of the insurance provider’s stock after acquiring an additional 293 shares during the quarter. Independence Bank of Kentucky’s holdings in Humana were worth $132,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. MV Capital Management Inc. boosted its position in shares of Humana by 40.8% during the first quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock worth $33,000 after buying an additional 20 shares during the period. MAI Capital Management lifted its position in shares of Humana by 2.6% in the first quarter. MAI Capital Management now owns 796 shares of the insurance provider’s stock worth $387,000 after purchasing an additional 20 shares in the last quarter. Humankind Investments LLC lifted its position in shares of Humana by 4.3% in the first quarter. Humankind Investments LLC now owns 513 shares of the insurance provider’s stock worth $249,000 after purchasing an additional 21 shares in the last quarter. Vestcor Inc lifted its position in shares of Humana by 0.3% in the fourth quarter. Vestcor Inc now owns 8,292 shares of the insurance provider’s stock worth $4,247,000 after purchasing an additional 22 shares in the last quarter. Finally, Trust Investment Advisors lifted its position in shares of Humana by 5.3% in the fourth quarter. Trust Investment Advisors now owns 441 shares of the insurance provider’s stock worth $226,000 after purchasing an additional 22 shares in the last quarter. 91.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
HUM has been the topic of a number of recent research reports. Argus downgraded Humana from a “buy” rating to a “hold” rating in a research report on Friday, June 23rd. StockNews.com initiated coverage on Humana in a research report on Thursday, August 17th. They issued a “buy” rating on the stock. Royal Bank of Canada lowered their target price on Humana from $637.00 to $594.00 and set an “outperform” rating on the stock in a research report on Thursday, August 3rd. Wells Fargo & Company decreased their target price on shares of Humana from $610.00 to $541.00 in a research note on Thursday, July 13th. Finally, TD Cowen decreased their target price on shares of Humana from $616.00 to $613.00 and set an “outperform” rating for the company in a research note on Tuesday, August 15th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $592.30.
Humana Stock Performance
NYSE:HUM opened at $470.63 on Friday. The stock has a fifty day moving average price of $467.45 and a 200-day moving average price of $487.11. The company has a market cap of $58.32 billion, a price-to-earnings ratio of 17.56, a PEG ratio of 1.22 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.37 and a current ratio of 1.37. Humana Inc. has a fifty-two week low of $423.29 and a fifty-two week high of $571.30.
Humana (NYSE:HUM – Get Free Report) last issued its earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 EPS for the quarter, beating the consensus estimate of $8.88 by $0.06. Humana had a net margin of 3.42% and a return on equity of 20.70%. The company had revenue of $26.75 billion during the quarter, compared to analysts’ expectations of $25.83 billion. During the same period in the previous year, the company earned $8.67 EPS. The business’s revenue for the quarter was up 13.0% compared to the same quarter last year. As a group, equities analysts anticipate that Humana Inc. will post 28.25 EPS for the current fiscal year.
Humana Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.75%. Humana’s payout ratio is currently 13.21%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Five stocks we like better than Humana
- How to Invest in Artificial Intelligence
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MarketBeat Week in Review – 9/11 – 9/15
- What is the Shanghai Stock Exchange Composite Index?
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.